Moderna stock

Moderna and Merck Cancer Vaccine Shows Promise in Late-Stage Trial as Stocks Surge

A closely watched cancer vaccine program from Moderna and Merck has delivered an important late-stage clinical trial result — and Wall Street reacted almost immediately. The...